Market Cap ₹171 Cr.
Stock P/E 8.0
P/B 1.5
Current Price ₹186.5
Book Value ₹ 128.6
Face Value 10
52W High ₹225.4
Dividend Yield 0.8%
52W Low ₹ 90
Rishiroop Limited is a company that manufactures and trades polymers and polymer compounds for various industries, such as rubber, plastic, coatings, personal care, and construction. Founded in 2000 and it is based in Mumbai, Maharashtra. It has two brands, Spitze and Everyday, that offer a range of products, such as chlorinated rubber, NBR/PVC blends, silicone rubber, carbon blacks, silanes, waxes, and rubber chemicals. It also provides customized solutions for its customers and has a technical application laboratory for coatings and personal care products. Rishiroop is part of the Amalgamations Group and has received several awards and certifications for its quality and innovation.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 17 | 20 | 24 | 25 | 25 | 24 | 20 | 17 | 20 | 20 |
| Other Income | 4 | 5 | 1 | -1 | 0 | 4 | 2 | 6 | 4 | 7 |
| Total Income | 21 | 24 | 25 | 24 | 25 | 28 | 21 | 24 | 24 | 27 |
| Total Expenditure | 13 | 16 | 20 | 22 | 26 | 21 | 18 | 16 | 18 | 18 |
| Operating Profit | 8 | 8 | 4 | 2 | -1 | 7 | 3 | 8 | 6 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 8 | 8 | 4 | 1 | -1 | 7 | 3 | 8 | 6 | 9 |
| Provision for Tax | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit After Tax | 7 | 6 | 3 | 1 | -1 | 6 | 2 | 7 | 5 | 8 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 7 | 6 | 3 | 1 | -1 | 6 | 2 | 7 | 5 | 8 |
| Adjusted Earnings Per Share | 6.9 | 6.4 | 3.5 | 0.8 | -1.3 | 6.1 | 2.7 | 7.4 | 4.9 | 8.4 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 44 | 36 | 28 | 38 | 47 | 60 | 61 | 41 | 55 | 84 | 89 | 77 |
| Other Income | 0 | 1 | 1 | 3 | 6 | 3 | 2 | 1 | 11 | 9 | 1 | 19 |
| Total Income | 44 | 36 | 29 | 41 | 53 | 64 | 63 | 41 | 66 | 94 | 90 | 96 |
| Total Expenditure | 41 | 33 | 27 | 37 | 43 | 51 | 54 | 44 | 48 | 71 | 78 | 70 |
| Operating Profit | 4 | 3 | 2 | 4 | 10 | 13 | 9 | -3 | 18 | 22 | 12 | 26 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 3 | 2 | 3 | 9 | 12 | 9 | -3 | 38 | 21 | 11 | 26 |
| Provision for Tax | 1 | 1 | 0 | 1 | 2 | 4 | 1 | -0 | 8 | 4 | 3 | 4 |
| Profit After Tax | 2 | 2 | 1 | 2 | 7 | 8 | 7 | -3 | 30 | 17 | 8 | 22 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 2 | 2 | 1 | 2 | 7 | 8 | 7 | -3 | 30 | 17 | 8 | 22 |
| Adjusted Earnings Per Share | 4.3 | 3.8 | 2.7 | 4.6 | 7.6 | 8.3 | 7.5 | -2.9 | 30.9 | 18.4 | 8.8 | 23.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 6% | 29% | 8% | 7% |
| Operating Profit CAGR | -45% | 0% | -2% | 12% |
| PAT CAGR | -53% | 0% | 0% | 15% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 90% | 20% | 30% | 22% |
| ROE Average | 8% | 23% | 15% | 13% |
| ROCE Average | 11% | 29% | 19% | 17% |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 18 | 20 | 20 | 55 | 63 | 61 | 67 | 61 | 86 | 94 | 100 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | -0 | 0 | 1 | 0 | -0 | 1 | 2 | 3 |
| Total Current Liabilities | 8 | 7 | 4 | 8 | 14 | 10 | 9 | 9 | 7 | 13 | 11 |
| Total Liabilities | 27 | 27 | 24 | 62 | 77 | 72 | 76 | 70 | 94 | 109 | 114 |
| Fixed Assets | 2 | 2 | 3 | 9 | 9 | 8 | 2 | 2 | 1 | 3 | 2 |
| Other Non-Current Assets | 0 | 3 | 10 | 29 | 38 | 31 | 38 | 29 | 44 | 56 | 59 |
| Total Current Assets | 24 | 21 | 12 | 24 | 31 | 33 | 35 | 40 | 49 | 50 | 53 |
| Total Assets | 27 | 27 | 24 | 62 | 77 | 72 | 76 | 70 | 94 | 109 | 114 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 1 | 2 | 2 | 2 | 1 | 3 | 4 | 3 | 2 | 3 |
| Cash Flow from Operating Activities | 6 | 2 | 3 | -1 | 1 | 0 | 6 | 2 | -11 | 16 | 14 |
| Cash Flow from Investing Activities | -4 | -0 | -2 | 1 | -1 | 13 | -4 | -1 | 16 | -6 | -12 |
| Cash Flow from Financing Activities | -1 | -1 | -1 | -0 | -1 | -13 | -1 | -3 | -5 | -10 | -2 |
| Net Cash Inflow / Outflow | -0 | 1 | 0 | -0 | -0 | 0 | 1 | -1 | -0 | 1 | -0 |
| Closing Cash & Cash Equivalent | 1 | 2 | 2 | 2 | 1 | 2 | 4 | 3 | 2 | 3 | 3 |
| # | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.32 | 3.83 | 2.65 | 4.62 | 7.58 | 8.32 | 7.53 | -2.93 | 30.92 | 18.39 | 8.84 |
| CEPS(Rs) | 4.97 | 4.49 | 3.49 | 5.89 | 8.38 | 8.98 | 7.99 | -2.37 | 31.42 | 19.19 | 9.7 |
| DPS(Rs) | 1.2 | 1.2 | 0.8 | 0.8 | 1 | 1.2 | 1.2 | 1 | 6.2 | 1.5 | 1.5 |
| Book NAV/Share(Rs) | 35.32 | 37.74 | 38.94 | 91.66 | 65.08 | 62.62 | 68.67 | 63.09 | 89.12 | 102.28 | 109.46 |
| Core EBITDA Margin(%) | 7.75 | 6.9 | 4.9 | 2.63 | 7.63 | 15.48 | 11.34 | -8.16 | 11.95 | 15.58 | 11.73 |
| EBIT Margin(%) | 8.03 | 7.95 | 6.31 | 8.34 | 19.51 | 20.15 | 14.46 | -7.59 | 70.92 | 25.51 | 12.46 |
| Pre Tax Margin(%) | 7.66 | 7.61 | 6.03 | 7.89 | 18.92 | 19.74 | 14.03 | -8.17 | 70.47 | 25.25 | 12.26 |
| PAT Margin (%) | 5.01 | 5.47 | 4.71 | 6.27 | 15.4 | 13.4 | 12.04 | -7.01 | 54.94 | 19.96 | 9.13 |
| Cash Profit Margin (%) | 5.76 | 6.41 | 6.19 | 7.82 | 17.03 | 14.45 | 12.78 | -5.68 | 55.82 | 20.84 | 10.02 |
| ROA(%) | 7.92 | 7.51 | 5.43 | 5.69 | 10.53 | 10.82 | 9.9 | -3.9 | 36.44 | 16.57 | 7.26 |
| ROE(%) | 12.77 | 10.49 | 6.92 | 7.23 | 13.26 | 13.04 | 11.47 | -4.45 | 40.63 | 18.7 | 8.35 |
| ROCE(%) | 20.23 | 15.17 | 9.26 | 8.7 | 15.79 | 19.61 | 13.77 | -4.82 | 52.45 | 23.9 | 11.4 |
| Receivable days | 65.69 | 64.35 | 60.73 | 52.22 | 57.24 | 52.94 | 54.3 | 77.64 | 66.65 | 57.44 | 57.66 |
| Inventory Days | 81.7 | 71.32 | 74.19 | 62.47 | 79.57 | 82.18 | 82.69 | 107 | 95.46 | 71.88 | 54.52 |
| Payable days | 85.8 | 71.63 | 62 | 48.91 | 76.1 | 75.99 | 65.21 | 87.56 | 60.08 | 51.09 | 56.56 |
| PER(x) | 4.75 | 6.32 | 10.53 | 6.33 | 7.08 | 12.57 | 7.44 | 0 | 2.63 | 6.42 | 10.04 |
| Price/Book(x) | 0.58 | 0.64 | 0.72 | 0.32 | 0.82 | 1.67 | 0.82 | 0.36 | 0.91 | 1.15 | 0.81 |
| Dividend Yield(%) | 5.84 | 4.96 | 2.86 | 2.74 | 1.86 | 1.15 | 2.14 | 4.36 | 7.61 | 1.27 | 1.69 |
| EV/Net Sales(x) | 0.23 | 0.31 | 0.46 | 0.54 | 1.08 | 1.65 | 0.83 | 0.47 | 1.39 | 1.24 | 0.88 |
| EV/Core EBITDA(x) | 2.58 | 3.43 | 5.69 | 5.36 | 5.01 | 7.79 | 5.43 | -7.51 | 4.21 | 4.7 | 6.6 |
| Net Sales Growth(%) | -28.42 | -19.25 | -19.91 | 34.73 | 21.75 | 29.08 | 0.61 | -33.14 | 34.64 | 54.58 | 5.1 |
| EBIT Growth(%) | -59.97 | -19.74 | -36.18 | 76.7 | 184.63 | 30.4 | -27.84 | -135.11 | 1357.83 | -44.4 | -48.65 |
| PAT Growth(%) | -62 | -11.39 | -30.75 | 77.96 | 198.63 | 9.78 | -9.58 | -138.91 | 1155.85 | -43.83 | -51.92 |
| EPS Growth(%) | -62 | -11.39 | -30.75 | 74.21 | 64.01 | 9.78 | -9.58 | -138.91 | 1155.86 | -40.54 | -51.92 |
| Debt/Equity(x) | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 3.14 | 3.22 | 3.04 | 3.26 | 2.26 | 3.27 | 4.08 | 4.31 | 7.13 | 3.9 | 4.75 |
| Quick Ratio(x) | 2.23 | 2.13 | 1.82 | 2.09 | 1.39 | 1.77 | 2.65 | 3.07 | 4.63 | 2.66 | 3.82 |
| Interest Cover(x) | 21.79 | 23.38 | 22.42 | 18.73 | 32.97 | 48.5 | 33.88 | -13.03 | 159.61 | 97.99 | 62.04 |
| Total Debt/Mcap(x) | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.17 | 73.17 | 73.31 | 73.31 | 73.31 | 73.31 | 73.31 | 73.31 | 73.31 | 73.31 |
| FII | 0.14 | 0.27 | 0.27 | 0.27 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 26.68 | 26.55 | 26.4 | 26.4 | 26.68 | 26.68 | 26.68 | 26.68 | 26.68 | 26.68 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
